cbdMD (YCBD) Liabilities from Discontinued Operations (2018)
cbdMD's (YCBD) quarterly Liabilities from Discontinued Operations came in at 7502.0 in Q3 2018.
cbdMD (YCBD) Liabilities from Discontinued Operations (2018) Analysis & Trends
cbdMD has disclosed Liabilities from Discontinued Operations across 1 years of filings, most recently posting 7502.0 for Q3 2018.
- Liabilities from Discontinued Operations for Q3 2018 came in at 7502.0, changed N/A year-over-year; the trailing twelve-month figure through Sep 2018 was 7502.0 (changed N/A YoY), and the FY2018 annual result was 7502.0, changed N/A from the prior year.
- Liabilities from Discontinued Operations came in at 7502.0 for Q3 2018 at cbdMD.
- In the past five years, Liabilities from Discontinued Operations ranged from a high of 7502.0 in Q3 2018 to a low of 7502.0 in Q3 2018.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.97 Bn | 36.23 Bn | 1.97 Bn |
| 2 | Zoetis | 33.59 Bn | 31.65 Bn | 1.62 Bn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn |
| 4 | Neurocrine Biosciences | 16.10 Bn | 14.78 Bn | 800.70 Mn |
| 5 | Aurora Cannabis | 15.56 Bn | 15.47 Bn | 21.72 Mn |
| 6 | Elanco Animal Health | 12.04 Bn | 11.61 Bn | 785.00 Mn |
| 7 | Alkermes | 7.36 Bn | 6.84 Bn | -116.06 Mn |
| 8 | Lantheus Holdings | 6.74 Bn | 6.24 Bn | 230.92 Mn |
| 9 | Liquidia | 6.27 Bn | 6.04 Bn | 121.79 Mn |
| 10 | cbdMD | 3,710.02 | -3.38 Mn | 3.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2018 | 7,502.00 |
| Sep 30, 2018 | 7,502.00 |